Neuraxis, Inc. (NRXS)
(Real Time Quote from BATS)
$2.50 USD
-0.02 (-0.79%)
Updated Aug 6, 2025 11:32 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NRXS 2.50 -0.02(-0.79%)
Will NRXS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NRXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXS
The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis
Top Stock Reports for Microsoft, NVIDIA & Bank of America
NRXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems
Other News for NRXS
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, ...
12 Health Care Stocks Moving In Monday's After-Market Session
Neuraxis management to meet with Craig-Hallum
NRXS: Minneapolis Meeting to Spotlight Key Developments | NRXS Stock News
Neuraxis management to meet with Craig-Hallum